Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy.

No single risk factor or drug cessation strategy was attributed to adverse clinical events after GI bleeding. The risk of future thrombotic or rebleeding events should be individualized and controlled for based on a pre-existing stratification system.